Cargando…

Prognostic characteristics and clinical response to immunotherapy targeting programmed cell death 1 for patients with advanced gastric cancer with liver metastases

BACKGROUND: The specific efficacy of immunotherapy for patients with liver metastases of gastric cancer is unclear. This study set out to explore the treatment response and related prognostic factors for patients with liver metastases of gastric cancer treated with immunotherapy. PATIENTS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Huayuan, Li, Zhiwei, Huang, Zhicheng, Wu, Chaorui, Qiu, Yaopeng, Liang, Yanrui, Chen, Xinhua, Li, Fengping, Xu, Zhou, Li, Guoxin, Liu, Hao, Zhao, Liying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532548/ https://www.ncbi.nlm.nih.gov/pubmed/36211361 http://dx.doi.org/10.3389/fimmu.2022.1015549

Ejemplares similares

Association of peripheral basophils with tumor M2 macrophage infiltration and outcomes of the anti-PD-1 inhibitor plus chemotherapy combination in advanced gastric cancer
por: Wu, Chaorui, et al.
Publicado: (2022)

Safety and short-term outcomes of laparoscopic surgery for advanced gastric cancer after neoadjuvant immunotherapy: A retrospective cohort study
por: Su, Jin, et al.
Publicado: (2022)

Relationship Between Programmed Death Ligand 1 Expression and Other Clinicopathological Features in a Large Cohort of Gastric Cancer Patients
por: Chen, Xinhua, et al.
Publicado: (2022)

Corrigendum: Relationship between programmed death ligand 1 expression and other clinicopathological features in a large cohort of gastric cancer patients
por: Chen, Xinhua, et al.
Publicado: (2023)

The prognostic biological markers of immunotherapy for non-small cell lung cancer: current landscape and future perspective
por: Liang, Shuai, et al.
Publicado: (2023)

An antigen processing and presentation signature for prognostic evaluation and immunotherapy selection in advanced gastric cancer
por: Wang, Ke-wei, et al.
Publicado: (2022)

Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
por: Palanivelu, Lalitha, et al.
Publicado: (2023)

Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer
por: Yang, Hao, et al.
Publicado: (2023)

Dysbiosis of Gastric Mucosal Fungal Microbiota in the Gastric Cancer Microenvironment
por: Zhang, Zhenzhan, et al.
Publicado: (2022)

SOX chemotherapy with anti-PD-1 and iNKT cell immunotherapies for stage IV gastric adenocarcinoma with liver metastases: A case report
por: Li, Dezhao, et al.
Publicado: (2022)

Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma
por: Liang, Zhongqing, et al.
Publicado: (2022)

N4‐Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF‐1α Positive Feedback Loop
por: Yang, Qingbin, et al.
Publicado: (2023)

Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer
por: Xia, Yan, et al.
Publicado: (2022)

The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies
por: Chen, Lei, et al.
Publicado: (2022)

N4‐Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF‐1α Positive Feedback Loop (Adv. Sci. 23/2023)
por: Yang, Qingbin, et al.
Publicado: (2023)

Research Progress Concerning Dual Blockade of Lymphocyte-Activation Gene 3 and Programmed Death-1/Programmed Death-1 Ligand-1 Blockade in Cancer Immunotherapy: Preclinical and Clinical Evidence of This Potentially More Effective Immunotherapy Strategy
por: Qi, Yihang, et al.
Publicado: (2021)

Prognostic value and nomograms of proximal margin distance in gastric cancer with radical distal gastrectomy
por: Luo, Jun, et al.
Publicado: (2020)

Emerging role of deubiquitination modifications of programmed death-ligand 1 in cancer immunotherapy
por: Jiang, Yao, et al.
Publicado: (2023)

Application of Regulatory Cell Death in Cancer: Based on Targeted Therapy and Immunotherapy
por: Qi, Xiaochen, et al.
Publicado: (2022)

Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM
por: Feng, Songshan, et al.
Publicado: (2022)

Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer
por: Wang, Gaoming, et al.
Publicado: (2022)

Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study
por: Liang, Yanrui, et al.
Publicado: (2021)

Correction to: Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study
por: Liang, Yanrui, et al.
Publicado: (2021)

Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer
por: Xu, Jiannan, et al.
Publicado: (2022)

A novel immunogenic cell death–related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer
por: Dong, Bingqi, et al.
Publicado: (2023)

Body composition parameters for predicting the efficacy of neoadjuvant chemotherapy with immunotherapy for gastric cancer
por: Lin, Guang-Tan, et al.
Publicado: (2022)

The worthy role of hepatic arterial infusion chemotherapy in combination with anti-programmed cell death protein 1 monoclonal antibody immunotherapy in advanced hepatocellular carcinoma
por: Ding, Yixin, et al.
Publicado: (2023)

Fibroblast-derived LPP as a biomarker for treatment response and therapeutic target in gastric cancer
por: Wang, Hao, et al.
Publicado: (2022)

Noninvasive imaging of the tumor immune microenvironment correlates with response to immunotherapy in gastric cancer
por: Huang, Weicai, et al.
Publicado: (2022)

Alkaline phosphatase combined with γ-glutamyl transferase is an independent predictor of prognosis of hepatocellular carcinoma patients receiving programmed death-1 inhibitors
por: Xu, Lei, et al.
Publicado: (2023)

Clinical outcomes and timing on the combination of focal radiation therapy and immunotherapy for the treatment of brain metastases
por: Antelo, Gabriela, et al.
Publicado: (2023)

Adenosine signaling: Optimal target for gastric cancer immunotherapy
por: Wang, Junqing, et al.
Publicado: (2022)

The role of the gut microbiota in gastric cancer: the immunoregulation and immunotherapy
por: Wang, Meiqi, et al.
Publicado: (2023)

LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response
por: Huang, Jihong, et al.
Publicado: (2022)

Identification of Malassezia globosa as a Gastric Fungus Associated with PD-L1 Expression and Overall Survival of Patients with Gastric Cancer
por: Zhang, Zhenzhan, et al.
Publicado: (2022)

Case report: Advanced primary squamous cell carcinoma in the periampullary area with upregulation of programmed cell death-ligand 1 expression and response to sintilimab immunotherapy
por: Wang, Baoshan, et al.
Publicado: (2023)

Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy
por: Qiu, Qin, et al.
Publicado: (2021)

Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer
por: Jin, Xin, et al.
Publicado: (2022)

Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients
por: Hu, Bo, et al.
Publicado: (2022)

Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers
por: Ai, Huihan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2vc0j38f0f963n6953l8564979